Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and TACE in advanced hepatocellular carcinoma
NCT01170104Phase 2Unknown
- Sponsor
- Chung-Ang University
- Start
- Jun 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Chung-Ang University. Status: unknown.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01170104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01170104.